Disposition of 159120 shares by Erdtmann Rainer M of Biomea Fusion at 7.5023 subject to Rule 16b-3
| BMEA Stock | USD 1.38 0.04 2.82% |
About 60% of Biomea Fusion's investor base is looking to short. The analysis of the overall investor sentiment regarding Biomea Fusion suggests that many traders are alarmed. The current market sentiment, together with Biomea Fusion's historical and current headlines, can help investors time the market. In addition, many technical investors use Biomea Fusion stock news signals to limit their universe of possible portfolio assets.
Filed transaction by Biomea Fusion Director, 10 Percent Owner, Officer President And Coo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Biomea Fusion's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Biomea Fusion's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Biomea Fusion Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Biomea Fusion can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Biomea Fusion Historical Investor Sentiment
Investor biases related to Biomea Fusion's public news can be used to forecast risks associated with an investment in Biomea. The trend in average sentiment can be used to explain how an investor holding Biomea can time the market purely based on public headlines and social activities around Biomea Fusion. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Biomea Fusion's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Biomea Fusion and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Biomea Fusion news discussions. The higher the estimate score, the more favorable the investor's outlook on Biomea Fusion.
Biomea Fusion Maximum Pain Price Across January 16th 2026 Option Contracts
Biomea Fusion's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Biomea Fusion close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Biomea Fusion's options.
Biomea Fusion Fundamental Analysis
We analyze Biomea Fusion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomea Fusion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomea Fusion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Biomea Fusion is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Biomea Fusion Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biomea Fusion stock to make a market-neutral strategy. Peer analysis of Biomea Fusion could also be used in its relative valuation, which is a method of valuing Biomea Fusion by comparing valuation metrics with similar companies.
Peers
Biomea Fusion Related Equities
| SPRB | Spruce Biosciences, | 1.21 | ||||
| ADVM | Adverum Biotechnologies | 0.47 | ||||
| ZNTL | Zentalis Pharmaceuticals | 0.58 | ||||
| ATYR | ATyr Pharma, | 1.03 | ||||
| PLRX | Pliant Therapeutics | 1.11 | ||||
| SRZN | Surrozen | 1.44 | ||||
| GUTS | Fractyl Health, | 1.54 | ||||
| CNTB | Connect Biopharma | 3.75 | ||||
| ACET | Adicet Bio | 4.44 | ||||
| ALXO | Alx Oncology | 9.41 |
Complementary Tools for Biomea Stock analysis
When running Biomea Fusion's price analysis, check to measure Biomea Fusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomea Fusion is operating at the current time. Most of Biomea Fusion's value examination focuses on studying past and present price action to predict the probability of Biomea Fusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomea Fusion's price. Additionally, you may evaluate how the addition of Biomea Fusion to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |